Williams Eugene Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$35,631.40
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Williams Eugene

According to the SEC Form 4 filings, Williams Eugene, being in a position of

  1. director at ProMIS Neurosciences, Inc.,
    оver the last 12 months, has bought 7316 shares for $146,471, and sold 0 shares,
    over all time since 2022-07-11, has bought 13316 shares for $182,102, and sold 0 shares.

Biography of Williams Eugene

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $146,4715100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-10-30PurchaseProMIS Neurosciences, Inc.
PMN
director
1,316
0.0174%
$3.99$5,251
2026-03-05PurchaseProMIS Neurosciences, Inc.
PMN
director
2,000
0.1505%
$24.40$48,800-51.82%
2026-03-04PurchaseProMIS Neurosciences, Inc.
PMN
director
2,000
0.1524%
$24.00$48,000-49.9%
2026-03-03PurchaseProMIS Neurosciences, Inc.
PMN
director
1,000
0.0735%
$21.89$21,890-50.71%
2026-03-02PurchaseProMIS Neurosciences, Inc.
PMN
director
1,000
0.0733%
$22.53$22,530-46.47%
2022-12-16PurchaseProMIS Neurosciences, Inc.
PMN
director
2,000
0.0251%
$4.64$9,290-12.9%
2022-12-12PurchaseProMIS Neurosciences, Inc.
PMN
director
1,000
0.0136%
$5.08$5,075-12.5%
2022-12-07PurchaseProMIS Neurosciences, Inc.
PMN
director
1,000
0.0133%
$5.49$5,486-20%
2022-12-02PurchaseProMIS Neurosciences, Inc.
PMN
director
1,000
0.0133%
$5.98$5,980-24.75%
2022-07-11PurchaseProMIS Neurosciences, Inc.
PMN
Chairman and CEO
1,000
0.0169%
$9.80$9,800-31.95%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.